Enlivex Therapeutics Ltd. (ENLV)
NASDAQ·Healthcare·Biotechnology
$0.85
-3.56%
Mkt Cap $28.19M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+1662.8%
Consensus $15.00 vs current $0.85
NASDAQ·Healthcare·Biotechnology
$0.85
-3.56%
Mkt Cap $28.19M
No recent rating data.
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+1662.8%
Consensus $15.00 vs current $0.85